Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment

Annual Review of Nutrition

Volumn 35, Issue 1, 2015, Pages 517-543

  Siri Tarino, Patty W ^a   Chiu, Sally ^a   Bergeron, Nathalie ^a,b   Krauss, Ronald M ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

Atherogenic dyslipidemia; Diet; Lipids; Metabolism; Sugar

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE; COCONUT OIL; FAT; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PALM OIL; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID; CARBOHYDRATE DIET; FAT INTAKE; FATTY ACID; UNSATURATED FATTY ACID;

ATHEROGENESIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; DAIRY PRODUCT; DIET; DIET SUPPLEMENTATION; DIETARY INTAKE; DYSLIPIDEMIA; EATING HABIT; FOOD COMPOSITION; FOOD QUALITY; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MACRONUTRIENT; MODULATION; NUTRITION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROCESSED MEAT; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RED MEAT; REVIEW; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FAT INTAKE; FERMENTED MILK PRODUCT; FISH; FOOD GRAIN; NUT; VEGETABLE;

ANIMALS; CARDIOVASCULAR DISEASES; CULTURED MILK PRODUCTS; DAIRY PRODUCTS; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; DYSLIPIDEMIAS; EDIBLE GRAIN; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FISHES; HUMANS; NUTS; VEGETABLES;

EID: 84937542322     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071714-034449     Document Type: Review

References (192)

1. Abete I, Romaguera D, Vieira AR, Lopez de Munain A, Norat T. 2014. Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies. Br. J. Nutr. 112:762-75
2. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, et al. 1997. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336:1117-24
3. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, et al. 2005. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294:2455-64
4. Astrup A. 2014. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am. J. Clin. Nutr. 99:1235-42S
5. Astrup A, Dyerberg J, Elwood P, Hermansen K, Hu FB, et al. 2011. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010? Am. J. Clin. Nutr. 93:684-88
6. Astrup A, Pedersen SD. 2012. Is a protein calorie better for weight control? Am. J. Clin. Nutr. 95:535-36
7. Austin MA, Hokanson JE, Edwards KL. 1998. Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81:7-12B
8. Azrad M, Turgeon C, Demark-Wahnefried W. 2013. Current evidence linking polyunsaturated fatty acids with cancer risk and progression. Front. Oncol. 3:224
9. Baer DJ, Judd JT, Clevidence BA, Tracy RP. 2004. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr. 79:969-73
10. Baylin A, Campos H. 2006. The use of fatty acid biomarkers to reflect dietary intake. Curr. Opin. Lipidol. 17:22-27
11. Bays HE, Tighe AP, Sadovsky R, Davidson MH. 2008. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev. Cardiovasc. Ther. 6:391-409
12. Bazzano LA, Hu T, Reynolds K, Yao L, Bunol C, et al. 2014. Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann. Intern. Med. 161:309-18
13. Behall KM, Howe JC. 1995. Effect of long-term consumption of amylose versus amylopectin starch on metabolic variables in human subjects. Am. J. Clin. Nutr. 61:334-40
14. Behall KM, Scholfield DJ, Yuhaniak I, Canary J. 1989. Diets containing high amylose versus amylopectin starch: effects on metabolic variables in human subjects. Am. J. Clin. Nutr. 49:337-44
15. Bergeron N, Havel RJ. 1995. Influence of diets rich in saturated and omega-6 polyunsaturated fatty acids on the postprandial responses of apolipoproteins B-48, B-100, E, and lipids in triglyceride-rich lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15:2111-21
16. Bergeron N, Havel RJ. 1997. Assessment of postprandial lipemia: nutritional influences. Curr. Opin. Lipidol. 8:43-52
17. Berglund L, Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, et al. 2007. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am. J. Clin. Nutr. 86:1611-20
18. Berneis KK, Krauss RM. 2002. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res. 43:1363-79
19. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. 2010. Major dietary protein sources and risk of coronary heart disease in women. Circulation 122:876-83
20. Biong AS, Muller H, Seljeflot I, Veierod MB, Pedersen JI. 2004. A comparison of the effects of cheese and butter on serum lipids, haemostatic variables and homocysteine. Br. J. Nutr. 92:791-97
21. Boren J, Matikainen N, Adiels M, Taskinen MR. 2014. Postprandial hypertriglyceridemia as a coronary risk factor. Clin. Chim. Acta 431:131-42
22. Brouwer IA, Wanders AJ, Katan MB. 2010. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans-A quantitative review. PLOS ONE 5:e9434
23. BuenoNB, de Melo IS, de Oliveira SL, da Rocha Ataide T. 2013. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br. J. Nutr. 110:1178-87
24. Chait A, Kim F. 2010. Saturated fatty acids and inflammation: Who pays the toll? Arterioscler. Thromb. Vasc. Biol. 30:692-93
25. Chang CL, Torrejon C, Jung UJ, Graf K, Deckelbaum RJ. 2014. Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/-mice. Atherosclerosis 234:401-9
26. Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, et al. 2008. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the Trans Fatty Acids Collaboration (TRANSFACT) study. Am. J. Clin. Nutr. 87:558-66
27. Chiu S, Williams PT, Dawson T, Bergman RN, Stefanovski D, et al. 2014. Diets high in protein or saturated fat do not affect insulin sensitivity or plasma concentrations of lipids and lipoproteins in overweight and obese adults. J. Nutr. 144:1753-59
28. Chong MF, Fielding BA, Frayn KN. 2007. Mechanisms for the acute effect of fructose on postprandial lipemia. Am. J. Clin. Nutr. 85:1511-20
29. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, et al. 2014. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann. Intern. Med. 160:398-406
30. Clifton PM, Condo D, Keogh JB. 2014. Long term weight maintenance after advice to consume low carbohydrate, higher protein diets-A systematic review and meta analysis. Nutr. Metab. Cardiovasc. Dis. 24:224-35
31. Cortese C, Levy Y, Janus ED, Turner PR, Rao SN, et al. 1983. Modes of action of lipid-lowering diets in man: studies of apolipoprotein B kinetics in relation to fat consumption and dietary fatty acid composition. Eur. J. Clin. Invest. 13:79-85
32. Cox C, Mann J, Sutherland W, Chisholm A, Skeaff M. 1995. Effects of coconut oil, butter, and safflower oil on lipids and lipoproteins in persons with moderately elevated cholesterol levels. J. Lipid Res. 36:1787-95
33. Cox C, Sutherland W, Mann J, de Jong S, Chisholm A, Skeaff M. 1998. Effects of dietary coconut oil, butter and safflower oil on plasma lipids, lipoproteins and lathosterol levels. Eur. J. Clin. Nutr. 52:650-54
34. Culling KS, Neil HA, Gilbert M, Frayn KN. 2009. Effects of short-term low-and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects. Nutr. Metab. Cardiovasc. Dis. 19:345-51
35. de LorgerilM,Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. 1999. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779-85
36. de Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, et al. 2012. Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am. J. Clin. Nutr. 96:397-404
37. Degirolamo C, Shelness GS, Rudel LL. 2009. LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J. Lipid Res. 50(Suppl.):S434-39
38. Denke MA. 1995. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am. J. Clin. Nutr. 62:471-77S
39. Denke MA, Adams-Huet B, Nguyen AT. 2000. Individual cholesterol variation in response to a margarine-or butter-based diet: a study in families. JAMA 284:2740-47
40. Diet. Guidel. Advis. Comm. 2015. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Dep. Health Human Serv. http://www.health.gov/dietaryguidelines/ 2015-scientific-report
41. Dong JY, Zhang YH, Wang P, Qin LQ. 2012. Meta-analysis of dietary glycemic load and glycemic index in relation to risk of coronary heart disease. Am. J. Cardiol. 109:1608-13
42. Dreon DM, Fernstrom HA, Campos H, Blanche P, Williams PT, Krauss RM. 1998. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am. J. Clin. Nutr. 67:828-36
43. Dreon DM, FernstromHA, Miller B, Krauss RM. 1995. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arterioscler. Thromb. Vasc. Biol. 15:105-11
44. Ebbeling CB, Swain JF, Feldman HA,WongWW,Hachey DL, et al. 2012. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA 307:2627-34
45. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, et al. 2014. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63:2960-84
46. Elwood PC, Pickering JE, Givens DI, Gallacher JE. 2010. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45:925-39
47. Elwood PC, Pickering JE, Hughes J, Fehily AM, Ness AR. 2004. Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur. J. Clin. Nutr. 58:718-24
48. Erkkila A, de Mello VD, Riserus U, Laaksonen DE. 2008. Dietary fatty acids and cardiovascular disease: an epidemiological approach. Prog. Lipid Res. 47:172-87
49. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, et al. 2013. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 368:1279-90
50. Farvid MS, Ding M, Pan A, SunQ, Chiuve SE, et al. 2014. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation 130:1568-78
51. Fattore E, Bosetti C, Brighenti F, Agostoni C, Fattore G. 2014. Palm oil and blood lipid-related markers of cardiovascular disease: a systematic review and meta-analysis of dietary intervention trials. Am. J. Clin. Nutr. 99:1331-50
52. Flock MR, Fleming JA, Kris-Etherton PM. 2014. Macronutrient replacement options for saturated fat: effects on cardiovascular health. Curr. Opin. Lipidol. 25:67-74
53. Flock MR, Green MH, Kris-Etherton PM. 2011. Effects of adiposity on plasma lipid response to reductions in dietary saturated fatty acids and cholesterol. Adv. Nutr. 2:261-74
54. Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kroger J, et al. 2014. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2:810-18
55. Forsythe CE, Phinney SD, Feinman RD, Volk BM, Freidenreich D, et al. 2010. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 45:947-62
56. Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, et al. 2008. Comparison of low fat and low carbohydrate diets on circulating fatty acids composition and markers of inflammation. Lipids 43:65-77
57. Fredenrich A. 1998. Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism. Diabetes Metab. 24:490-95
58. Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. 2009. Sweetened beverage consumption and risk of coronary heart disease in women. Am. J. Clin. Nutr. 89:1037-42
59. Furtado JD, Campos H, Appel LJ, Miller ER, Laranjo N, et al. 2008. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. Am. J. Clin. Nutr. 87:1623-30
60. Gardner CD. 2012. Tailoring dietary approaches for weight loss. Int. J. Obes. Suppl. 2:S11-15
61. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, et al. 2007. Comparison of the Atkins, Zone, Ornish, andLEARNdiets for change in weight and related risk factors among overweight premenopausal women. The A TO Z Weight Loss Study: a randomized trial. JAMA 297:969-77
62. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D Agostino RB Sr, et al. 2014. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63:2935-59
63. Gogebakan O, Kohl A, Osterhoff MA, van Baak MA, Jebb SA, et al. 2011. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors. The Diet, Obesity, and Genes (DiOGenes) study: a randomized, controlled trial. Circulation 124:2829-38
64. Goldbohm RA, Chorus AM, Galindo Garre F, Schouten LJ, van den Brandt PA. 2011. Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am. J. Clin. Nutr. 93:615-27
65. Guay V, Lamarche B, Charest A, Tremblay AJ, Couture P. 2012. Effect of short-term low-and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects. Metabolism 61:76-83
66. Halton TL, Willett WC, Liu S, Manson JE, Albert CM, et al. 2006. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N. Engl. J. Med. 355:1991-2002
67. Harvey KA, Walker CL, Xu Z, Whitley P, Pavlina TM, et al. 2010. Oleic acid inhibits stearic acidinduced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cells. J. Lipid Res. 51:3470-80
68. Hayes KC, Khosla P, Hajri T, Pronczuk A. 1997. Saturated fatty acids and LDL receptor modulation in humans and monkeys. Prostaglandins Leukot. Essent. Fatty Acids 57:411-18
69. Heijnen ML, van Amelsvoort JM, Deurenberg P, Beynen AC. 1996. Neither raw nor retrograded resistant starch lowers fasting serum cholesterol concentrations in healthy normolipidemic subjects. Am. J. Clin. Nutr. 64:312-18
70. Hjerpsted J, Leedo E, Tholstrup T. 2011. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am. J. Clin. Nutr. 94:1479-84
71. Hodson L, Skeaff CM, Fielding BA. 2008. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47:348-80
72. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, et al. 2014. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler. Thromb. Vasc. Biol. 34:1069-77
73. Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, et al. 2012. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev. 5:CD002137
74. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, et al. 2006. Low-fat dietary pattern and risk of cardiovascular disease: the Women s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295:655-66
75. Hu FB. 2010. Are refined carbohydrates worse than saturated fat? Am. J. Clin. Nutr. 91:1541-42
76. Hu FB, Stampfer MJ, Manson JE, Ascherio A, Colditz GA, et al. 1999. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am. J. Clin. Nutr. 70:1001-8
77. Huff MW, Nestel PJ. 1982. Metabolism of apolipoproteins CII, CIII1, CIII2 and VLDL-B in human subjects consuming high carbohydrate diets. Metabolism 31:493-98
78. Jakobsen MU, Dethlefsen C, Joensen AM, Stegger J, Tjonneland A, et al. 2010. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am. J. Clin. Nutr. 91:1764-68
79. Jakobsen MU, O Reilly EJ, Heitmann BL, Pereira MA, Balter K, et al. 2009. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr. 89:1425-32
80. Jansen S, Lopez-Miranda J, Salas J, Castro P, Paniagua JA, et al. 1998. Plasma lipid response to hypolipidemic diets in young healthy non-obese men varies with body mass index. J. Nutr. 128:1144-49
81. Jebb SA, Lovegrove JA, Griffin BA, Frost GS, Moore CS, et al. 2010. Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am. J. Clin. Nutr. 92:748-58
82. Jenkins DJ, Vuksan V, Kendall CW, Wursch P, Jeffcoat R, et al. 1998. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J. Am. Coll. Nutr. 17:609-16
83. Jenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, et al. 2009. The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch. Intern. Med. 169:1046-54
84. Jimenez-Gomez Y, López-Miranda J, Blanco-Colio LM, Marin C, Perez-Martinez P, et al. 2009. Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Atherosclerosis 204:e70-76
85. Johnston BC, Kanters S, Bandayrel K, Wu P, Naji F, et al. 2014. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 312:923-33
86. Karupaiah T, Tan CH, Chinna K, Sundram K. 2011. The chain length of dietary saturated fatty acids affects human postprandial lipemia. J. Am. Coll. Nutr. 30:511-21
87. Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM. 2006. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 114:681-87
88. Keogh JB, Grieger JA, Noakes M, Clifton PM. 2005. Flow-mediated dilatation is impaired by a highsaturated fat diet but not by a high-carbohydrate diet. Arterioscler. Thromb. Vasc. Biol. 25:1274-79
89. Keys A, Aravanis C, Blackburn HW, Van Buchem FS, Buzina R, et al. 1966. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med. Scand. Suppl. 460:1-392
90. Khosla P, Hayes KC. 2012. Saturated fat and lipemia: importance of study design and triglyceride structure. Am. J. Clin. Nutr. 96:216-18; author reply 218-19
91. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, et al. 2013. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19:576-85
92. Krauss RM. 2005. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 25:2265-72
93. Krauss RM. 2014. All low-density lipoprotein particles are not created equal. Arterioscler. Thromb. Vasc. Biol. 34:959-61
94. Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. 2006. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am. J. Clin. Nutr. 83:1025-31; quiz 1205
95. Krauss RM, Siri PW.2004. Metabolic abnormalities: triglyceride and low-density lipoprotein. Endocrinol. Metab. Clin. North Am. 33:405-15
96. Kummerow FA. 2013. Interaction between sphingomyelin and oxysterols contributes to atherosclerosis and sudden death. Am. J. Cardiovasc. Dis. 3:17-26
97. Lairon D, Defoort C. 2011. Effects of nutrients on postprandial lipemia. Curr. Vasc. Pharmacol. 9:309-12
98. Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, et al. 2010. Diets with high or low protein content and glycemic index for weight-loss maintenance. N. Engl. J. Med. 363:2102-13
99. Lee JE, McLerran DF, Rolland B, Chen Y, Grant EJ, et al. 2013. Meat intake and cause-specific mortality: a pooled analysis of Asian prospective cohort studies. Am. J. Clin. Nutr. 98:1032-41
100. Lefevre M, Champagne CM, Tulley RT, Rood JC, Most MM. 2005. Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am. J. Clin.Nutr. 82:957-63; quiz 1145-46
101. Liebman BF, Katan MB, Jacobson MF. 2014. Association of dietary, circulating, and supplement fatty acids with coronary risk. Ann. Intern. Med. 161:454-55
102. Livesey G, Taylor R, Hulshof T, Howlett J. 2008. Glycemic response and health-A systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes.Am. J. Clin. Nutr. 87:258-68S
103. Lorenzen JK, Astrup A. 2011. Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet. Br. J. Nutr. 105:1823-31
104. Maki KC, Van Elswyk ME, Alexander DD, Rains TM, Sohn EL, McNeill S. 2012. A meta-analysis of randomized controlled trials that compare the lipid effects of beef versus poultry and/or fish consumption. J. Clin. Lipidol. 6:352-61
105. Mangravite LM, Chiu S, Wojnoonski K, Rawlings RS, Bergeron N, Krauss RM. 2011. Changes in atherogenic dyslipidemia induced by carbohydrate restriction in men are dependent on dietary protein source. J. Nutr. 141:2180-85
106. Manning PJ, Sutherland WH, McGrath MM, de Jong SA, Walker RJ, Williams MJ. 2008. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 16:2046-52
107. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, et al. 2012. The VITaminDand OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 33:159-71
108. Martinez-Gonzalez MA, Zazpe I, Razquin C, Sanchez-Tainta A, Corella D, et al. 2014. Empiricallyderived food patterns and the risk of total mortality and cardiovascular events in the PREDIMED study. Clin. Nutr. doi: 10.1016/j.clnu.2014.09.006
109. Masson CJ, Mensink RP. 2011. Exchanging saturated fatty acids for (n-6) polyunsaturated fatty acids in a mixed meal may decrease postprandial lipemia and markers of inflammation and endothelial activity in overweight men. J. Nutr. 141:816-21
110. Inst. Med (IOM). 2010. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: Natl. Acad. Press
111. Mensink RP, Katan MB. 1992. Effect of dietary fatty acids on serum lipids and lipoproteins. A metaanalysis of 27 trials. Arterioscler. Thromb. 12:911-19
112. Mensink RP, Zock PL, Katan MB, Hornstra G. 1992. Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans. J. Lipid Res. 33:1493-501
113. Mensink RP, Zock PL, Kester AD, Katan MB. 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77:1146-55
114. Mente A, de Koning L, Shannon HS, Anand SS. 2009. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 169:659-69
115. Micha R, Mozaffarian D. 2010. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 45:893-905
116. Micha R, Wallace SK, Mozaffarian D. 2010. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 121:2271-83
117. Miller PE, Van Elswyk M, Alexander DD. 2014. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am. J. Hypertens. 27:885-96
118. Mora S, Caulfied MP, Wohlgemuth J, Chen Z, Superko HR, Glynn RJ, Ridker PM, Krauss RM. 2015. Atherogenic lipoprotein subclasses determined by ion mobility analysis and first cardiovascular events after random allocation to high-intensity statin therapy or placebo: the JUPITER Trial. Manuscript submitted
119. Mozaffarian D. 2008. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am. J. Clin. Nutr. 87:1991-96S
120. Mozaffarian D, Appel LJ, Van Horn L. 2011. Components of a cardioprotective diet: new insights. Circulation 123:2870-91
121. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, et al. 2010. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. Adults: a cohort study. Ann. Intern. Med. 153:790-99
122. Mozaffarian D, Clarke R. 2009. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur. J. Clin. Nutr. 63(Suppl. 2):S22-33
123. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. 2006. Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 354:1601-13
124. Mozaffarian D, MichaR, Wallace S. 2010. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLOS Med. 7:e1000252
125. Muller H, Lindman AS, Brantsaeter AL, Pedersen JI. 2003. The serum LDL/HDL cholesterol ratio is influenced more favorably by exchanging saturated with unsaturated fat than by reducing saturated fat in the diet of women. J. Nutr. 133:78-83
126. Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, et al. 2009. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 29:1975-80
127. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, et al. 2002. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J. Am. Coll. Cardiol. 39:1145-50
128. Nestel PJ, Chronopulos A, Cehun M. 2005. Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 59:1059-63
129. Nicholls SJ, Lundman P, Harmer JA, Cutri B, Griffiths KA, et al. 2006. Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J. Am. Coll. Cardiol. 48:715-20
130. Noakes M, Clifton PM, Nestel PJ, Le Leu R, McIntosh G. 1996. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am. J. Clin.Nutr. 64:944-51
131. Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, et al. 2006. Effects of low-carbohydrate versus low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 166:285-93
132. O Connor LM, Lentjes MA, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. 2014. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 57:909-17
133. Odegaard AO, Koh WP, Yuan JM, Gross MD, Pereira MA. 2014. Dietary patterns and mortality in a Chinese population. Am. J. Clin. Nutr. 100:877-83
134. Ordovas JM. 2006. Genetic interactions with diet influence the risk of cardiovascular disease. Am. J. Clin. Nutr. 83:443-46S
135. Parish S, Offer A, Clarke R, Hopewell JC, Hill MR, et al. 2012. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation 125:2469-78
136. Poppitt SD, Keogh GF, Lithander FE, Wang Y, Mulvey TB, et al. 2008. Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-α, and C-reactive protein to a high-fat dietary load. Nutrition 24:322-29
137. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. 2010. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br. J. Nutr. 104:1586-600
138. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, et al. 2013. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 346:e8707
139. Ras RT, Streppel MT, Draijer R, Zock PL. 2013. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int. J. Cardiol. 168:344-51
140. Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, et al. 2006. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects.Am. J. Clin. Nutr. 83:221-26
141. Raz O, Steinvil A, Berliner S, Rosenzweig T, Justo D, Shapira I. 2013. The effect of two iso-caloric meals containing equal amounts of fats with a different fat composition on the inflammatory and metabolic markers in apparently healthy volunteers. J. Inflamm. (Lond.) 10:3
142. Rees K, Hartley L, Flowers N, Clarke A, Hooper L, et al. 2013. "Mediterranean" dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 8:CD009825
143. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. 2012. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308:1024-33
144. Roche MM, Wang PP. 2013. Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care 36:2582-90
145. Rudel LL, Parks JS, Sawyer JK. 1995. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:2101-10
146. Sacks FM. 2015. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Curr. Opin. Lipidol. 26:56-63
147. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, et al. 2009. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 360:859-73
148. Sacks FM, Carey VJ, Anderson CA, Miller ER 3rd, Copeland T, et al. 2014. Effects of high versus low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb Randomized Clinical Trial. JAMA 312:2531-41
149. Saito H, Kagaya M, Suzuki M, Yoshida A, Naito M. 2013. Simultaneous ingestion of fructose and fat exacerbates postprandial exogenous lipidemia in young healthy Japanese women. J. Atheroscler. Thromb. 20:591-600
150. Sanders TA, Filippou A, Berry SE, Baumgartner S, Mensink RP. 2011. Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am. J. Clin. Nutr. 94:1433-41
151. Sanders TA, Lewis FJ, Goff LM, Chowienczyk PJ, Group RS. 2013. SFAs do not impair endothelial function and arterial stiffness. Am. J. Clin. Nutr. 98:677-83
152. Schwingshackl L, Hoffmann G. 2013. Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr. J. 12:48
153. Serra-Majem L, Roman B, Estruch R. 2006. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr. Rev. 64:S27-47
154. Shepherd J, Packard CJ, Grundy SM, Yeshurun D, GottoAMJr, Taunton OD. 1980. Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J. Lipid Res. 21:91-99
155. Shikany JM, Tinker LF, Neuhouser ML, Ma Y, Patterson RE, et al. 2010. Association of glycemic load with cardiovascular disease risk factors: the Women s Health Initiative Observational Study. Nutrition 26:641-47
156. Shin MJ, Krauss RM. 2010. Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men. Atherosclerosis 211:337-41
157. Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, et al. 2012. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann. Intern. Med. 156:291-304
158. Simopoulos AP. 2008. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 233:674-88
159. Siri-TarinoPW,SunQ,Hu FB, Krauss RM. 2010. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr. 91:535-46
160. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. 2010. Saturated fat, carbohydrate, and cardiovascular disease. Am. J. Clin. Nutr. 91:502-9
161. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. 2010. Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr. Atheroscler. Rep. 12:384-90
162. Siri-Tarino PW, Williams PT, Fernstrom HS, Rawlings RS, Krauss RM. 2009. Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity (Silver Spring) 17:1768-75
163. Skeaff CM, Miller J. 2009. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann. Nutr. Metab. 55:173-201
164. Sluijs I, Forouhi NG, Beulens JW, van der Schouw YT, Agnoli C, et al. 2012. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am. J. Clin. Nutr. 96:382-90
165. Soedamah-Muthu SS, Ding EL, Al-DelaimyWK,HuFB, Engberink MF, et al. 2011. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 93:158-71
166. Sofi F, Abbate R, Gensini GF, Casini A. 2010. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am. J. Clin. Nutr. 92:1189-96
167. Stanhope KL, Bremer AA, Medici V, Nakajima K, Ito Y, et al. 2011. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J. Clin. Endocrinol. Metab. 96:E1596-605
168. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, et al. 2009. Consuming fructosesweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119:1322-34
169. Te Morenga LA, Howatson AJ, Jones RM, Mann J. 2014. Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am. J. Clin. Nutr. 100:165-79
170. Tholstrup T, Hoy CE, Andersen LN, Christensen RD, Sandstrom B. 2004. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently? J. Am. Coll. Nutr. 23:169-76
171. Tierney AC, McMonagle J, Shaw DI, GulsethHL, Helal O, et al. 2011. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int. J. Obes. (Lond.) 35:800-9
172. Tsai MY, Steffen BT, Guan W, McClelland RL, Warnick R, et al. 2014. New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-Ethnic Study of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 34:196-201
173. Turner JD, Le NA, BrownWV.1981. Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man. Am. J. Physiol. 241:E57-63
174. Vafeiadou K, Weech M, Sharma V, Yaqoob P, Todd S, et al. 2012. A review of the evidence for the effects of total dietary fat, saturated, monounsaturated and n-6 polyunsaturated fatty acids on vascular function, endothelial progenitor cells and microparticles. Br. J. Nutr. 107:303-24
175. Vessby B, Uusitupa M, Hermansen K,Riccardi G, Rivellese AA, et al. 2001. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 44:312-19
176. Virtanen JK, Mursu J, Tuomainen T, Voutilainen S. 2014. Dietary fatty acids and risk of coronary heart diesase in men: the Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler. Thromb. Vasc. Biol. 34:2679-87
177. Volk BM, Kunces LJ, Freidenreich DJ, Kupchak BR, Saenz C, et al. 2014. Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome. PLOS ONE 9:e113605
178. Voon PT, Ng TK, Lee VK, Nesaretnam K. 2011. Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am. J. Clin. Nutr. 94:1451-57
179. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, et al. 2006. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primaryand secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 84:5-17
180. Wang D, Sievenpiper JL, de Souza RJ, Cozma AI, Chiavaroli L, et al. 2014. Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 232:125-33
181. Warensjo E, Jansson JH, Cederholm T, Boman K, Eliasson M, et al. 2010. Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. Am. J. Clin. Nutr. 92:194-202
182. Weggemans RM, Zock PL, Urgert R, Katan MB. 1999. Differences between men and women in the response of serum cholesterol to dietary changes. Eur. J. Clin. Invest. 29:827-34
183. Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB. 2010. Caloric sweetener consumption and dyslipidemia among US adults. JAMA 303:1490-97
184. Westerterp-Plantenga MS, Nieuwenhuizen A, Tome D, Soenen S, Westerterp KR. 2009. Dietary protein, weight loss, and weight maintenance. Annu. Rev. Nutr. 29:21-41
185. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, et al. 2007. Low-carbohydrate nutrition and metabolism. Am. J. Clin. Nutr. 86:276-84
186. Wijendran V, Hayes KC. 2004. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu. Rev. Nutr. 24:597-615
187. Willett WC, Stampfer MJ, Sacks FM. 2014. Association of dietary, circulating, and supplement fatty acids with coronary risk. Ann. Intern. Med. 161:453
188. WuJH, Lemaitre RN, King IB, Song X, Psaty BM, et al. 2014. Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation 130:1245-53
189. Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. 2012. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 96:1281-98
190. Yamagishi K, Iso H, Kokubo Y, Saito I, Yatsuya H, et al. 2013. Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study. Eur. Heart J. 34:1225-32
191. Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. 2014. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern. Med. 174:516-24
192. Yao Z, Wang Y. 2012. Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production. Curr. Opin. Lipidol. 23:206-12